Microvascular Rarefaction and Myocardial Fibrosis in Hypertrophic Obstructive Cardiomyopathy

被引:7
|
作者
Tian, Hongwei
Yang, Chengzhi
Song, Yunhu
Wang, Hongyue
Yuan, Jiansong
Cui, Jingang
Liu, Shengwen
Hu, Fenghuan
Yang, Weixian
Jiang, Xiaowei
Qiao, Shubin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, State Key Lab Cardiovasc Dis, 167 North Lishi Rd, Beijing, Peoples R China
[2] Peking Union Med Coll, 167 North Lishi Rd, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Microvascular density; Myocardial fibrosis; Hypertrophic obstructive cardiomyopathy; HEART-FAILURE; TISSUE; DYSFUNCTION; DISARRAY; COLLAGEN; YOUNG;
D O I
10.1159/000493005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a myocardial disease characterized by fibrosis and microvascular ischemia. Microvessels play a critical role in myocardial fibrosis in HOCM. However, it remains unclear whether or not myocardial fibrosis is associated with microvascular density (MVD) changes. Objective: The aim of the present study was to investigate whether a reduction in MVD is related to myocardial fibrosis in HOCM cardiac samples. Methods: We analyzed MVD and fibrosis in myectomy left ventricular (LV) septal wall specimens from 53 HOCM patients. Control myocardium from the LV septal wall was collected at autopsy of 9 individuals who died of noncardiac causes. Results: The fibrosis ratio (% area) in HOCM was higher and the MVD was lower than that in control subjects (i.e., 12.7 +/- 10.0 vs. 4.0 +/- 1.4%, p = 0.012, and 480.9 +/- 206.7 vs. 1,425 +/- 221/mm(2), p < 0.001). Patients with mild fibrosis had a higher MVD than patients with moderate fibrosis (i.e., 568.2 +/- 214.8 vs. 403.2 +/- 167.8/mm(2), p = 0.006) and patients with severe fibrosis (i.e., 568.2 +/- 214.8 vs. 378.6 +/- 154.0/mm(2), p =0.024). Furthermore, a significant negative correlation was found between myocardial fibrosis and MVD in HOCM patients (r = -0.40, p = 0.003), which was also found in mild fibrosis (r = -0.40, p = 0.043), moderate fibrosis (r = -0.50, p = 0.024), and severe fibrosis (r = -0.24, p = 0.61), although no significant differences were observed in severe fibrosis. Additionally, we demonstrated that late gadolinium enhancement was negatively correlated with MVD (r = -0.37, p = 0.03) and positively correlated with fibrosis (r = 0.44, p = 0.01). Conclusion: HOCM patients had a higher myocardial fibrosis ratio and a lower MVD. The severity of myocardial fibrosis was negatively correlated with MVD in HOCM. These findings showed that a reduced MVD may contribute to myocardial fibrosis in HOCM. (C) 2019 S. Karger AG, Basel
引用
收藏
页码:202 / 211
页数:10
相关论文
共 50 条
  • [31] NONSURGICAL MYOCARDIAL REDUCTION FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    SIGWART, U
    LANCET, 1995, 346 (8969): : 211 - 214
  • [32] Myocardial Histopathology in Patients With Obstructive Hypertrophic Cardiomyopathy
    Cui, Hao
    Schaff, Hartzell, V
    Carvalho, Juliano Lentz
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Dearani, Joseph A.
    Lahr, Brian D.
    Lee, Alexander T.
    Bos, J. Martijn
    Ackerman, Michael J.
    Ommen, Steve R.
    Maleszewski, Joseph J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (17) : 2159 - 2170
  • [33] MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY SEEN BY MRI
    Pastrama, Miguel A.
    Fraga, Patricia
    Cavero, Miguel A.
    Peraira, J. Roberto
    RADIOLOGIA, 2005, 47 (06): : 340 - 340
  • [34] Myocardial Blood Flow and Fibrosis in Hypertrophic Cardiomyopathy
    Aquaro, Giovanni Donato
    Todiere, Giancarlo
    Barison, Andrea
    Strata, Elisabetta
    Marzilli, Mario
    Pingitore, Alessandro
    Lombardi, Massimo
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (05) : 384 - 391
  • [35] Diffuse myocardial fibrosis in pediatric hypertrophic cardiomyopathy
    Tarique Hussain
    Andrea Dragulescu
    Lee Benson
    Derek Wong
    Mark Friedberg
    Luc Mertens
    Shi-Joon Yoo
    Lars Grosse-Wortmann
    Journal of Cardiovascular Magnetic Resonance, 15 (Suppl 1)
  • [36] SANDOSTATIN DECREASES MYOCARDIAL FIBROSIS IN HYPERTROPHIC CARDIOMYOPATHY
    TARABEN, A
    CAMPBELL, SE
    JONES, J
    KOPPLIN, D
    KHARDORI, R
    CIRCULATION, 1995, 92 (08) : 2521 - 2521
  • [37] Genetic regulation of myocardial fibrosis in hypertrophic cardiomyopathy
    Patel, V.
    Syrris, P.
    Coats, C.
    Lucena, J.
    Lara-Pezzi, E.
    Garcia-Pavia, P.
    Elliott, P. M.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1778 - 1778
  • [38] Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
    O'Hanlon, Rory
    Grasso, Agata
    Roughton, Michael
    Moon, James C.
    Clark, Susan
    Wage, Ricardo
    Webb, Jessica
    Kulkarni, Meghana
    Dawson, Dana
    Sulaibeekh, Leena
    Chandrasekaran, Badri
    Bucciarelli-Ducci, Chiara
    Pasquale, Ferdinando
    Cowie, Martin R.
    McKenna, William J.
    Sheppard, Mary N.
    Elliott, Perry M.
    Pennell, Dudley J.
    Prasad, Sanjay K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (11) : 867 - 874
  • [39] Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
    Ho, Carolyn Y.
    Lopez, Begona
    Coelho-Filho, Otavio R.
    Lakdawala, Neal K.
    Cirino, Allison L.
    Jarolim, Petr
    Kwong, Raymond
    Gonzalez, Arantxa
    Colan, Steven D.
    Seidman, J. G.
    Diez, Javier
    Seidman, Christine E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (06): : 552 - 563
  • [40] Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy
    Hanlon, R. O'
    Grasso, A.
    Roughton, M.
    Moon, J. C.
    Wage, W.
    Bucciarelli-Ducci, C.
    Mckenna, W. J.
    Elliott, P. M.
    Pennell, D. J.
    Prasad, S. K.
    EUROPEAN HEART JOURNAL, 2010, 31 : 331 - 331